Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FNCB 'moderately effective' at retrieving clinically-useful GI samples
The team reviewed GI samples from 25 dogs and 19 cats obtained by fine needle cytology biopsies.
Study published in the JSAP reviewed GI samples from 25 dogs and 19 cats.

Ultrasound-guided fine needle cytology biopsies (FNCB) are moderately effective at retrieving clinically-useful samples from gastrointestinal lesions (GI lesions), according to new research.

Published in the Journal of Small Animal Practice, the study aimed to assess factors that may influence the clinical usefulness of samples collected from GI lesions by FNCB. The team reviewed GI samples from 25 dogs and 19 cats obtained by FNCB from a single institution between February 2014 to August 2016.

Researchers evaluated the clinical records to obtain historical data, clinical findings, diagnostic results and patient outcomes. Lesion thickness was categorised further as either a mass (≥20 mm thickness) or a thickening (<20mm).

The team also reviewed factors that may have influenced the retrieval of a clinically useful sample. These included the lesion location, sonographic lesion thickness, the loss of (or alteration to) the intestinal layer conspicuity on ultrasound, and the number of slides submitted to the cytologists.

Study author Dr Robert Turner, a registrar in veterinary radiology at the University of Melbourne, said: “Of the submitted cytological samples, 68 per cent (30/44) were considered clinically useful, including 11 of 18 from the stomach, eight of 12 from the small intestine, five of six from the ileocaecal junction and six of eight cases from the colon.

"The study found that both increasing lesion thickness and the number of slides submitted to the cytologists were positively associated with the odds of obtaining a clinically useful sample. In a multivariable logistic regression model, some evidence was obtained that these factors were related, but the available data was insufficient to precisely estimate their combined effect.”

JSAP editor, Nicola Di Girolamo, concluded: “The results of this study indicate that ultrasound-guided percutaneous cytology is moderately effective at retrieving clinically useful samples from GI lesions. Future research including larger, prospective studies would help to ascertain safety of this diagnostic technique, potential inter-operator variability, as well as a pragmatic comparison in terms of patient outcomes with the current standards for diagnosing GI lesions.”

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.